ACUTA CAPITAL PARTNERS, LLC - Q2 2023 holdings

$148 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 35 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was - .

 Value Shares↓ Weighting
NewDISC MEDICINE INC$6,193,800139,500
+100.0%
4.20%
PRAX NewPRAXIS PRECISION MEDICINES I$4,887,5004,250,000
+100.0%
3.31%
CLNN NewCLENE INC$3,731,5204,240,846
+100.0%
2.53%
IKNA NewIKENA ONCOLOGY INC$3,660,480558,000
+100.0%
2.48%
IMVT NewIMMUNOVANT INC$2,689,092141,755
+100.0%
1.82%
NewVERASTEM INC$2,232,000300,000
+100.0%
1.51%
NewROIVANT SCIENCES LTDshares$2,217,600220,000
+100.0%
1.50%
MORF NewMORPHIC HOLDING INC$1,003,27517,500
+100.0%
0.68%
ARWR NewARROWHEAD PHARMACEUTICALS INC$980,65027,500
+100.0%
0.66%
OLMA NewOLEMA PHARMACEUTICALS INC$955,500105,814
+100.0%
0.65%
BMEA NewBIOMEA FUSION INC$878,00040,000
+100.0%
0.60%
DYN NewDYNE THERAPEUTICS INC$821,25073,000
+100.0%
0.56%
KRON NewKRONOS BIO INC$541,800315,000
+100.0%
0.37%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IOVANCE BIOTHERAPEUTICS INC24Q1 202321.2%
KURA ONCOLOGY INC. COMMON STOCK20Q2 20248.1%
IRIDEX CORP20Q3 20198.1%
ARROWHEAD PHARMACEUTICALS INC20Q2 20237.9%
IMMUNOMEDICS INC19Q3 202020.6%
VERACYTE INC19Q3 201910.1%
APELLIS PHARMACEUTICALS INC18Q4 202318.4%
ASCENDIS PHARMA A S18Q2 20207.2%
XENON PHARMACEUTICALS INC18Q3 20224.6%
CAS MED SYS PAR $0.00418Q1 20196.4%

View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ACUTA CAPITAL PARTNERS, LLC Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BCLS Acquisition Corp.Sold outFebruary 14, 202300.0%
Jiya Acquisition Corp.Sold outFebruary 14, 202300.0%
VistaGen Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Larimar Therapeutics, Inc.Sold outFebruary 15, 202200.0%
CATALYST BIOSCIENCES, INC.Sold outFebruary 14, 202200.0%
Aadi Bioscience, Inc.September 07, 20211,529,4027.2%
Kadmon Holdings, Inc.February 14, 20207,373,3334.6%
IRIDEX CORPSold outNovember 13, 201900.0%
ASSEMBLY BIOSCIENCES, INC.February 14, 2019718,5002.8%
CAS MEDICAL SYSTEMS INCFebruary 14, 20195,263,50818.2%

View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14

View ACUTA CAPITAL PARTNERS, LLC's complete filings history.

Compare quarters

Export ACUTA CAPITAL PARTNERS, LLC's holdings